肺舒坦定量吸入劑 100/6mcg/dose

Šalis: Taivanas

kalba: kinų

Šaltinis: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Veiklioji medžiaga:

BECLOMETHASONE DIPROPIONATE;;FORMOTEROL FUMARATE DIHYDRATE

Prieinama:

友華生技醫藥股份有限公司 臺北市北投區承德路6段128號13樓 (12397982)

ATC kodas:

R03AK08

Vaisto forma:

口腔吸入劑

Sudėtis:

FORMOTEROL FUMARATE DIHYDRATE (1216003030) MG; BECLOMETHASONE DIPROPIONATE (8406000310) MG

Vienetai pakuotėje:

鋁罐瓶裝

Klasė:

製 劑

Recepto tipas:

須由醫師處方使用

Pagaminta:

CHIESI FARMACEUTICI S.P.A. VIA S. LEONARDO 96, 43122 PARMA, ITALY IT

Gydymo sritis:

formoterol and beclometasone

Terapinės indikacijos:

氣喘:Foster適用於需規律使用吸入型皮質類固醇與長效beta 2致效劑合併治療的氣喘病患。慢性阻塞性肺病(COPD):患有較嚴重之慢性阻塞性肺病(FEV1少於預測值之50%)及有反覆惡化病史,已定期使用長效型支氣管擴張劑,而仍有明顯症狀病患之治療。

Produkto santrauka:

有效日期: 2024/09/18; 英文品名: Foster

Leidimo data:

2009-09-18

Pakuotės lapelis

                                0108012397/01
BLACK + HALFT%
P 032 C
I certify here by under my personal responsibility that the signed
text is in full compliance with the official version approved
by the relevant regulatory Authority and in agreement with all
regulations in force in the country, where the product will be
distributed.
Approved & Proceed
JOB TITLE:
Name (in capital letter):
Signature:
Date:
Amend & Re-Submit
APPROVAL ARTWORK
CHIESI FARMACEUTICI S.P.A. - PARMA - ITALY
NOT TO TAMPER THIS DOCUMENT
ARTWORK OWNER: RB/EURPACK - MAIL: R.BOSELLI@CHIESI.COM
DIECUT
NAME:
DATE:
CHECK BY
PROOF N. / DATE
23/11/22
/
FROM: /CHANGE FOR
(1) DESCRIPTION OF MATERIAL:
(4) ITEM CHIESI:
(2) FORMAT:
DIMENSIONS MM:
(5) REPLACE CODE:
FONT AND MIN. SIZE:
REF. STD VARNISH:
COLOUR PRINT N.: 2
REASON OF THE CHANGE: CODE 29988 FOSTER MDI HFA 100+6MCG 120D
TAIWAN/OEP
RELOCATION
MASTER: PDF WITH CLIENT
1
F.E.FOSTER 6+100 MCG 120D MDI HFA TW
0108012397/01
F091
180 X 800 (AFTER FOLD 180 X 39)
0108008507/01
TEXT CONVERTED
/
PAG. 1/2
FRONT
0108012397/01
BLACK + HALFT%
P 032 C
I certify here by under my personal responsibility that the signed
text is in full compliance with the official version approved
by the relevant regulatory Authority and in agreement with all
regulations in force in the country, where the product will be
distributed.
Approved & Proceed
JOB TITLE:
Name (in capital letter):
Signature:
Date:
Amend & Re-Submit
APPROVAL ARTWORK
CHIESI FARMACEUTICI S.P.A. - PARMA - ITALY
NOT TO TAMPER THIS DOCUMENT
ARTWORK OWNER: RB/EURPACK - MAIL: R.BOSELLI@CHIESI.COM
DIECUT
NAME:
DATE:
CHECK BY
PROOF N. / DATE
23/11/22
/
FROM: /CHANGE FOR
(1) DESCRIPTION OF MATERIAL:
(4) ITEM CHIESI:
(2) FORMAT:
DIMENSIONS MM:
(5) REPLACE CODE:
FONT AND MIN. SIZE:
REF. STD VARNISH:
COLOUR PRINT N.: 2
REASON OF THE CHANGE: CODE 29988 FOSTER MDI HFA 100+6MCG 120D
TAIWAN/OEP
RELOCATION
MASTER: PDF WITH CLIENT
1
F.E.FOSTER 6+100 MCG 120D MDI HFA TW
0108012397/01
F091
180 X 800 (AFTER FOLD 180 X 39)
0108008507/01
TEXT CONVERTED
/
PAG. 2/2
BACK
                                
                                Perskaitykite visą dokumentą